Moreover, Analysis of MESP2 expression levels in GC patient tumors using the R2: Genomics Analysis and Visualization Platform (https://hgserver1.amc.nl/cgi-bin/r2) consistently confirmed that MESP2 upregulation predicted better patient survival (Fig. 1G–J). This evidence concerns the gene MESP2 and gastric cancer.